Quality of life and psychological disorders in Egyptian patients with chronic lung diseases: Clinico-physiological correlation

Morsi, Tamer S.; Ghobashy, Soha; Younis, Gihan

doi:10.1016/j.ejcdt.2014.02.005

Cited by 7 publications

(5 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After the selection process, 40 articles involving 21,747 participants [ 41 – 80 ] were included in the meta-analysis (Fig. 1 ) of which 31 articles were prevalence studies [ 42 – 46 , 48 , 50 – 54 , 57 , 59 – 61 , 63 – 65 , 67 – 73 , 75 – 80 ] and 9 articles were case-control studies [ 41 , 47 , 49 , 55 , 56 , 58 , 62 , 66 , 74 ] (Additional file 1 : Table S1 and Additional file 2 : Table S2). These articles had been published between 1993 and 2016.…”

Section: Resultsmentioning

confidence: 99%

“…The female/male sex ratio was 0.7 for the case-control studies. The subjects enrolled were hospitalised patients in 13 prevalence studies [ 46 , 48 , 50 , 53 , 54 , 57 , 64 , 67 , 71 , 76 , 78 – 80 ] and 3 analytical studies [ 47 , 49 , 74 ]. Non-hospitalised subjects had been studied in 18 prevalence studies [ 42 – 45 , 51 , 52 , 59 – 61 , 63 , 65 , 68 – 70 , 72 , 73 , 75 , 77 ] and 6 analytical studies [ 41 , 55 , 56 , 58 , 62 , 66 ].…”

Section: Resultsmentioning

confidence: 99%

“…Three of the 40 studies had been conducted amongst people with mental disorders who had been screened for chronic physical diseases; two of these were prevalence studies [ 52 , 75 ] and one was an analytical study [ 74 ]. Thirty seven studies had been conducted amongst people with chronic physical diseases who were screened for mental disorders; twenty nine of these were prevalence studies [ 42 – 46 , 48 , 50 , 51 , 53 , 54 , 57 , 59 – 61 , 63 – 65 , 67 – 73 , 76 – 80 ] and 8 were case-control studies [ 41 , 47 , 49 , 55 , 56 , 58 , 62 , 66 ]. There was one multicentre study conducted in Asia amongst the prevalence studies [ 70 ] which was considered in our meta-analysis.…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Co-morbidities of mental disorders and chronic physical diseases in developing and emerging countries: a meta-analysis

et al. 2019

View full text Add to dashboard Cite

BackgroundAs the data on the association of mental disorders and chronic physical diseases in developing and emerging countries is heterogeneous, this study aims to produce the first meta-analysis of these comorbidities.MethodologyThe meta-analysis protocol was registered in PROSPERO (N°CRD42017056521) and was performed in accordance with PRISMA guidelines. Initially, an article search was conducted on Medline, Embase, Lilacs and the Institut d’Epidémiologie et de Neurologie Tropicale database [Institute of Epidemiology and Tropical Neurology], as well as manually, with no restriction on language or date focusing on mental disorders, chronic diseases and neurotropic diseases. Two independent investigators assessed the quality of the studies which met the inclusion criteria using the Downs and Black assessment grid. The pooled estimates were calculated out using a random-effects method with CMA software Version 3.0. A meta-regression was then performed, and the significance level was set at 0.05.ResultsOf the 2604 articles identified, 40 articles involving 21,747 subjects met the inclusion criteria for co-morbidities between mental disorders and chronic physical diseases. Thirty-one articles were included in the meta-analysis of prevalence studies and 9 articles in that of the analytical studies. The pooled prevalence of mental disorders in patients with chronic physical diseases was 36.6% (95% CI, 31.4–42.1) and the pooled odds ratio was 3.1 (95% CI, 1.7–5.2). There was heterogeneity in all the estimates and in some cases, this was explained by the quality of the studies.ConclusionSome estimates regarding the prevalence of mental disorders in people with chronic physical diseases living in developing and emerging countries were similar to those in developed countries. Mental disorders are a burden in these countries. In order to respond effectively and efficiently to the morbidity and mortality associated with them, mental health care could be integrated with physical care.Electronic supplementary materialThe online version of this article (10.1186/s12889-019-6623-6) contains supplementary material, which is available to authorized users.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Co-morbidities of mental disorders and chronic physical diseases in developing and emerging countries: a meta-analysis

et al. 2019

View full text Add to dashboard Cite

show abstract

“…The most studied country was the USA with 13 HRQoL [ 27 – 40 ] and eight economic evidence publications [ 41 – 48 ]. From low income and lower middle income countries (using the World Bank definition [ 49 ]) we identified two studies on HRQoL from Egypt [ 50 , 51 ] and one from India [ 52 ]. From east Asia the predominant country was Japan with nine HRQoL studies [ 53 – 61 ]; one study was identified from China (HRQoL) [ 62 ] and one from Korea (costs) [ 63 ].…”

Section: Resultsmentioning

confidence: 99%

The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review

Διαμαντόπουλος¹,

Wright²,

Vlahopoulou³

et al. 2018

PharmacoEconomics

View full text Add to dashboard Cite

BackgroundIdiopathic pulmonary fibrosis (IPF) is a debilitating condition with significant morbidity and poor survival. Since 2010, there has been increased activity in the development of treatments that aim to delay progression of the disease.ObjectiveOur study involves a comprehensive review of the literature for evidence on health-related quality of life (HRQoL), healthcare resource use (HCRU) and costs, and an assessment of the burden of illness of the condition.MethodsWe carried out a systematic literature review (SLR) to identify economic evaluations and HRQoL studies. We searched EMBASE, MEDLINE and MEDLINE In Process for relevant studies from database origins to April 2017. Alongside the presentation of the study characteristics and the available evidence, we carried out a qualitative comparison using reference population estimates for HRQoL and national health expenditure for costs.ResultsOur search identified a total of 3241 records. After removing duplicates and not relevant articles, we analysed 124 publications referring to 88 studies published between 2000 and 2017. Sixty studies were HRQoL and 28 were studies on costs or HCRU. We observed an exponential growth of publications in the last 3–5 years, with the majority of the studies conducted in Europe and North America. Among the HRQoL studies, and despite regional differences, there was some agreement between estimates on the absolute and relative level of HRQoL for patients with IPF compared with the general population. Regarding costs, after adjustments for the cost years and currency, the suggested annual per capita cost of patients with IPF in North America was estimated around US$20,000, 2.5–3.5 times higher than the national healthcare expenditure. Additionally, studies that analysed patients with IPF alongside a matched control cohort suggested a significant increase in resource use and cost.ConclusionThe reviewed evidence indicates that IPF has considerable impact on HRQoL, relative to the general population levels. Furthermore, in studies of cost and resource use, most estimates of the burden were consistent in suggesting an excess cost for patients with IPF compared with a control cohort or the national health expenditure. This confirms IPF as a growing threat for public health worldwide, with considerable impact to the patients and healthcare providers.Electronic supplementary materialThe online version of this article (10.1007/s40273-018-0631-8) contains supplementary material, which is available to authorized users.

show abstract

“…A cross-sectional study of anxiety and depression in patients with CRDs revealed a high prevalence of anxiety and depression using the PRIME-MD (80%) [10]. Furthermore, according to the results of a 2014 survey in Egypt, 61.5% of a group of patients who suffered from CRDs had an anxiety disorder, and 58% had a depressive disorder [11]. To our knowledge, however, no studies have been published on anxiety and depression in Moroccan patients with CRDs.…”

Section: Introductionmentioning

confidence: 99%

Anxiety and Depression in Patients With Chronic Respiratory Diseases in the Fès-Meknès Region of Morocco

Bahra,

Amara,

Bourkhime

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

Quality of life and psychological disorders in Egyptian patients with chronic lung diseases: Clinico-physiological correlation

Cited by 7 publications

References 39 publications

Co-morbidities of mental disorders and chronic physical diseases in developing and emerging countries: a meta-analysis

Co-morbidities of mental disorders and chronic physical diseases in developing and emerging countries: a meta-analysis

The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review

Anxiety and Depression in Patients With Chronic Respiratory Diseases in the Fès-Meknès Region of Morocco

Contact Info

Product

Resources

About